A randomized, double-blind, placebo-controlled trial to assess the efficAcy and safety of Trimetazidine in patients with angina pectoris having been treated by percutaneous coronary intervention (ATPCI study): Rationale, design, and baseline characteristics

Angina Pectoris ◽

Controlled Trial ◽

Coronary Intervention ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Percutaneous Coronary ◽

Baseline Characteristics

Efficacy and safety of Shen-Yuan-Dan capsules for peri-procedural myocardial injury following percutaneous coronary intervention: study protocol for a randomized, double-blind, placebo-controlled trial

Annals of Translational Medicine ◽

10.21037/atm.2018.09.44 ◽

2019 ◽

Vol 7 (6) ◽

pp. 119-119

Author(s):

Xiang Li ◽

Xiao-Lei Lai ◽

Yu-Tong Fei ◽

Ju-Ju Shang ◽

Qi Zhou ◽

...

Keyword(s):

Study Protocol ◽

Myocardial Injury ◽

Intervention Study ◽

Controlled Trial ◽

Coronary Intervention ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Efficacy and safety of trimetazidine after percutaneous coronary intervention (ATPCI): a randomised, double-blind, placebo-controlled trial

The Lancet ◽

10.1016/s0140-6736(20)31790-6 ◽

2020 ◽

Vol 396 (10254) ◽

pp. 830-838 ◽

Cited By ~ 6

Author(s):

Roberto Ferrari ◽

Ian Ford ◽

Kim Fox ◽

Jean Pascal Challeton ◽

Anne Correges ◽

...

Keyword(s):

Controlled Trial ◽

Coronary Intervention ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

A multi-center randomized double-blind placebo-controlled trial of Xiongshao Capsule (芎芍胶囊) in preventing restenosis after percutaneous coronary intervention: A subgroup analysis of senile patients

Chinese Journal of Integrative Medicine ◽

10.1007/s11655-011-0843-7 ◽

2011 ◽

Vol 17 (9) ◽

pp. 669-674 ◽

Cited By ~ 27

Author(s):

Qing-hua Shang ◽

Hao Xu ◽

Xiao-yan Lu ◽

Chuan Wen ◽

Da-zhuo Shi ◽

...

Keyword(s):

Subgroup Analysis ◽

Controlled Trial ◽

Coronary Intervention ◽

Double Blind ◽

Double Blind Placebo ◽

Xiongshao Capsule ◽

Pentoxifylline for treatment of major depression after percutaneous coronary intervention or coronary artery bypass grafting: A randomized, double-blind, placebo-controlled trial

Journal of Psychosomatic Research ◽

10.1016/j.jpsychores.2021.110635 ◽

2021 ◽

pp. 110635

Author(s):

Seyyede-Ozra Yasrebi ◽

Sara Momtazmeaneh ◽

Hossein Sanjari Moghaddam ◽

Nazila Shahmansouri ◽

Maryam Mehrpooya ◽

...

Keyword(s):

Coronary Artery ◽

Coronary Artery Bypass Grafting ◽

Controlled Trial ◽

Artery Bypass ◽

Coronary Intervention ◽

Bypass Grafting ◽

Double Blind ◽

Double Blind Placebo ◽

Ranolazine in patients with incomplete revascularisation after percutaneous coronary intervention (RIVER-PCI): a multicentre, randomised, double-blind, placebo-controlled trial

The Lancet ◽

10.1016/s0140-6736(15)00459-6 ◽

2016 ◽

Vol 387 (10014) ◽

pp. 136-145 ◽

Cited By ~ 59

Author(s):

Giora Weisz ◽

Philippe Généreux ◽

Andres Iñiguez ◽

Aleksander Zurakowski ◽

Michael Shechter ◽

...

Keyword(s):

Controlled Trial ◽

Coronary Intervention ◽

Double Blind ◽

Double Blind Placebo ◽

Effects on Suxiao Jiuxin Pills in the Treatment of Patients with Acute Coronary Syndrome Undergoing Early Percutaneous Coronary Intervention: A Multicenter Randomized Double-Blind Placebo-Controlled Trial

The Journal of Alternative and Complementary Medicine ◽

10.1089/acm.2020.0014 ◽

2020 ◽

Vol 26 (11) ◽

pp. 1055-1063

Author(s):

Zhijie Shen ◽

Tiejun Chen ◽

Bing Deng ◽

Ming Fan ◽

Junyi Hua ◽

...

Keyword(s):

Acute Coronary Syndrome ◽

Controlled Trial ◽

Coronary Intervention ◽

Double Blind ◽

Double Blind Placebo ◽

Coronary Syndrome ◽

Rationale and design of the EMBRACE STEMI Study: A phase 2a, randomized, double-blind, placebo-controlled trial to evaluate the safety, tolerability and efficacy of intravenous Bendavia on reperfusion injury in patients treated with standard therapy including primary percutaneous coronary intervention and stenting for ST-segment elevation myocardial infarction

American Heart Journal ◽

10.1016/j.ahj.2012.12.008 ◽

2013 ◽

Vol 165 (4) ◽

pp. 509-514.e7 ◽

Cited By ~ 59

Author(s):

Anjan K. Chakrabarti ◽

Kristin Feeney ◽

Cassandra Abueg ◽

David A. Brown ◽

Ewa Czyz ◽

...

Keyword(s):

Myocardial Infarction ◽

Controlled Trial ◽

Coronary Intervention ◽

Double Blind ◽

Double Blind Placebo ◽

St Segment Elevation ◽

Segment Elevation Myocardial Infarction ◽

St Segment ◽

Letter of comment on “Intracoronary nitroprusside for the prevention of the no-reflow phenomenon after primary percutaneous coronary intervention in acute myocardial infarction. A randomized, double-blind, placebo-controlled clinical trial” (Am Heart J 2006;152:887.e9-14)

American Heart Journal ◽

10.1016/j.ahj.2007.01.015 ◽

2007 ◽

Vol 153 (5) ◽

pp. e25

Author(s):

Tom Vydt ◽

Pierfrancesco Agostoni

Keyword(s):

Myocardial Infarction ◽

Acute Myocardial Infarction ◽

Clinical Trial ◽

Coronary Intervention ◽

Controlled Clinical Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Percutaneous Coronary ◽

No Reflow Phenomenon

Evaluation of the effect of oral verapamil on clinical outcome and angiographic restenosis after percutaneous coronary intervention: The randomized, double-blind, placebo-controlled, multicenter verapamil slow-release for prevention of cardiovascular events after angioplasty (VESPA) trial

ACC Current Journal Review ◽

10.1016/j.accreview.2004.07.092 ◽

2004 ◽

Vol 13 (8) ◽

pp. 38

Author(s):

H.P. Bestehorn ◽

F.J. Neumann ◽

H.J. Büttneret

Keyword(s):

Clinical Outcome ◽

Cardiovascular Events ◽

Slow Release ◽

Coronary Intervention ◽

Double Blind ◽

Double Blind Placebo ◽

Angiographic Restenosis ◽

Percutaneous Coronary ◽

Oral Verapamil

Effect of Shenzhu Guanxin Recipe (参术冠心方) on patients with angina pectoris after percutaneous coronary intervention: A prospective, randomized controlled trial

Chinese Journal of Integrative Medicine ◽

10.1007/s11655-015-2040-6 ◽

2015 ◽

Vol 21 (6) ◽

pp. 408-416 ◽

Cited By ~ 7

Author(s):

Dan-ping Xu ◽

Huan-lin Wu ◽

Tao-hua Lan ◽

Xia Wang ◽

Xiao-gang Sheng ◽

...

Keyword(s):

Randomized Controlled Trial ◽

Angina Pectoris ◽

Controlled Trial ◽

Coronary Intervention ◽

Randomized Controlled ◽

Prospective Randomized Controlled Trial ◽